Title	Date	Price
Isis Pharmaceuticals Inc - Competitor Report The Isis Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...	Jan, 2007	€375
Ista Pharmaceuticals Inc - Competitor Report The Ista Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...	Jan, 2007	€375
Javelin Pharmaceuticals Inc - Competitor Report The Javelin Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...	Mar, 2006	€375
Johnson & Johnson - Competitor Report The Johnson & Johnson Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...	Jan, 2007	€375
K V Pharmaceutical Co CL A - Competitor Report The K V Pharmaceutical Co CL A Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...	Jan, 2007	€375
Kendle International Inc - Competitor Report The Kendle International Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...	Mar, 2006	€375
Keryx Biopharmaceuticals Inc - Competitor Report The Keryx Biopharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...	Jan, 2007	€375
King Pharmaceuticals Inc - Competitor Report The King Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...	Jan, 2007	€375
KOS Pharmaceuticals Inc - Competitor Report The KOS Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...	Oct, 2006	€375
Blue Cross Blue Shield of Massachusetts Business Intelligence Report Blue Cross Blue Shield of Massachusetts (BCBSMA) has 2.5 million members and is New Englands largest health plan, with more than 1.2 million HMO members. In 1992, BCBSMA launched its premier product,...	Mar, 2004	€369
Kosan Biosciences Incorporated - Competitor Report The Kosan Biosciences Incorporated Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...	Jan, 2007	€375
Kyphon Inc - Competitor Report The Kyphon Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...	Mar, 2006	€375
Kyto BioPharma Inc - Competitor Report The Kyto BioPharma Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...	Jan, 2007	€375
L A M Pharmaceutical Corp - Competitor Report The L A M Pharmaceutical Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...	Oct, 2006	€375
Labopharm Inc - Competitor Report The Labopharm Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...	Mar, 2006	€375
Lannett Co Inc - Competitor Report The Lannett Co Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...	Jan, 2007	€375
Large Scale Biology Corporation - Competitor Report The Large Scale Biology Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...	Mar, 2006	€375
Lee Pharmaceuticals - Competitor Report The Lee Pharmaceuticals Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...	Jan, 2007	€375
Lescarden Inc - Competitor Report The Lescarden Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...	Jan, 2007	€375
Lev Pharmaceuticals Inc - Competitor Report The Lev Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with...	Jan, 2007	€375